← Back to Dashboard

Obatoclax

Bcl-2 family inhibitor

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CC1=CC(=C(N1)C=C2C(=CC(=C3C=C4C=CC=CC4=N3)N2)OC)C
RFTSSZJZXOSICM-GRSHGNNSSA-N

Clinical Development by Virus14

Preclinical
Preclinical
Phase 2
Phase 3
Approved
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Influenza A virus
FLUAV
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus B
ECHOV-1
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human metapneumovirus
HMPV
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human alphaherpesvirus 2
HSV-2
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Argentinian mammarenavirus
JUNV
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Lassa mammarenavirus
LASV
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Rift Valley fever phlebovirus
RVFV
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Sindbis virus
SINV
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
West Nile virus
WNV
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Yellow fever virus
YFV
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Zika virus
ZIKV
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Lujo mammarenavirus
LUJV
Target: Human MCL1
Preclinical
Preclinical
Phase 2
Phase 3
Approved